Currently, there are 208.94M common shares owned by the public and among those 168.06M shares have been available to trade.
The company’s stock has a 5-day price change of 7.92% and -14.21% over the past three months. FRSH shares are trading -48.36% year to date (YTD), with the 12-month market performance down to -43.45% lower. It has a 12-month low price of $10.96 and touched a high of $24.98 over the same period. FRSH has an average intraday trading volume of 2.32 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 1.32%, -2.32%, and -30.25% respectively.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Institutional ownership of Freshworks Inc (NASDAQ: FRSH) shares accounts for 46.75% of the company’s 208.94M shares outstanding.
It has a market capitalization of $3.66B and a beta (3y monthly) value of 0.73. The earnings-per-share (ttm) stands at -$0.35. Price movements for the stock have been influenced by the stock’s volatility, which stands at 3.11% over the week and 3.55% over the month.
Earnings per share for the fiscal year are expected to increase by 28.31%, and 22.61% over the next financial year. EPS should shrink at an annualized rate of 30.00% over the next five years, compared to 32.03% over the past 5-year period.
Looking at the support for the FRSH, a number of firms have released research notes about the stock. Robert W. Baird stated their Neutral rating for the stock in a research note on May 02, 2024, with the firm’s price target at $28-$16. Wolfe Research was of a view on February 20, 2024 that the stock is Outperform, while Jefferies gave the stock Buy rating on January 05, 2024, issuing a price target of $20- $30. Needham on their part issued Buy rating on December 28, 2023.
